TrialFrontiers in immunology2023

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.

María Belén Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.